2010
187
Boer, G.J.,Transplantation and xenotransplantation. Ethics of cell therapy in the brain revisited. In J.J. Giordino and B. Gordijn, Scientific and philosophical perspectives in neuroethics, Chapter 9, Cambridge University Press (2010) 190-215

2009
186
Tannemaat, M.R., Boer, G.J., Eggers, R., Malessy, M.J., Verhaagen, J., From microsurgery to nanosurgery: how viral vectors may help repair the peripheral nerve, Prog Brain Res. 175, 173-186 (2009)

2008
185
Eggers, R., Hendriks, W.T., Tannemaat, M.R., van Heerikhuize, J.J., Pool, C.W., Carlstedt, T.P., Zaldumbide, A.T., Hoeben, R.C., Boer, G.J., Verhaagen, J., Neuroregenerative effects of reimplantation of genetically modified roots in a rat model for ventral spinal nerve avulsion, Molecular and Cellular Neuroscience, 39, 105-117 (2008)
184
Tannemaat, M.R., Eggers, R., Hendriks, W.T., de Ruiter, G.C., van Heerikhuize, J.J., Pool, C.W., Malessy, M.J., Boer, G.J., Verhaagen, J., Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve, Eur. J. Neurosci. 28 (2008) 1467-1479

2007
183
Boer, G.J., Neurotransplantation and gene transfer. In Merkel, R., Boer, G., Fegert, J., Galert, T., Hartmann, D., Nuttin, B., Rosahl, S. (Eds.), Intervening in the brain, changing psyche and society, Ethics of Science and Technology Assessment, Vol 29, Springer Verlag, Berkin Heidelberg (2007)
182
Boer, G.J., Gene transfer for central nervous system regeneration, Proceedings Educational Program ESGT 2007 “Neuro-Skeleto-Muscular Diseases” (2007) 99-111
181
Hendriks, W.T.J., Eggers, R., Verhaagen, J., Boer, G.J., Gene Transfer to the Spinal Cord Neural Scar with Lentiviral Vectors: Predominant Transgene Expression in Astrocytes but Not in Meningeal Cells, J. Neuroscience Res. 85, 3041–3052 (2007)
180
Tannemaat , M., Boer, G.J., Verhaagen, J., Malessy, M., Genetic modification of human sural nerve segments by a lentiviral vector encoding nerve growth factor, Neurosurgery 61, 1286–1296(2007)
179
Hendriks, W.T.J., Eggers, R., Carlstedt, T.P., Zaldumbide, A., Tannemaat, M.R., Hoeben, R.C., Boer. G.J., Verhaagen, J., Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune “stealth” transgene. Rest. Neurol. Neuroscience 25, 585-599 (2007)
178
Tannemaat, M. R., Korecka J., Ehlert, E.M.E., Mason, M.R.J., van Duinen, S.G., Boer, G.J., Malessy. M.A.J., Verhaagen, J., Human neuroma contains increased levels of semaphorin 3A, which surrounds nerve fibres and reduces neurite extension in vitro, J. Neuroscience, 27, 14260–64 (2007)

2006
177
Boer, G.J., Ethical issues in the approaches of restorative therapies for Parkinson’s disease, In Restorative therapies in Parkinson’s disease, eds. W. Olanow and P. Brundin, Kluwer, New York (2006) 13-49
176
Hendriks, W.T.J., Eggers, R., Ruitenberg, M.J.,Blits, B., Hamers, F.T.P., Verhaagen, J., Boer, G.J., Profound Differences in Spontaneous Long-Term Functional Recovery after Defined Spinal Tract Lesions in the Rat, J. Neurotrauma 23, 18-35 (2006)
175
Ruitenberg, M.J., Hendriks, W.J.T., Boer, G.J., Verhaagen, J., Gene therapy for spinal cord injury. In: Gene therapy in the central nervous system, eds. Kaplitt, M.G. and During, M. (2006) 273-288
174
Oudega, M., Blits, B., Verhaagen J., Boer, G.J., Introduction: experimental strategies to repair the injured spinal cord, J. Neurotrauma 23, 261-262 (2006)

2004
173
Hendriks, W.T.J., Ruitenberg, M.J., Blits, B., Boer, G.J., Verhaagen, J., Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord, Progress Brain Research 146, 451-476 (2004)
172
Blits, B, Carlstedt, T.P., Ruitenberg, M.J., De Winter, F, Hermens, W.T.J.M.C., Dijkhuizen, P.A., Claasens, J.W.C., Eggers, R., Van der Sluis, R, Tenenbaum, L., Boer G.J., Verhaagen, J., Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intrspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor, Exp. Neurol. 189, 303-316 (2004)

2003
171
Blits, B., Oudega, M,. Boer, G.J., Bartlett Bunge, M., Verhaagen, J., Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function, Neuroscience 118, 271-281 (2003)
170
Ruitenberg, M.J., Plant, G.W., Hamers, F.P.T., Wortel, J., Blits, B., Dijkhuizen, P.A., Gispen, W.-H., Boer, G.J., Verhaagen, J., Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheating glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord, J. Neuroscience 23, 7045-7058 (2003)
169
Boer, G.J., 'Ethics and politics of embryonic and fetal tissue transplants', Movement Disorder Society Newsletter, 2003

2002
168
De Wert, G., Berghmans, R., Boer, G.J., Andersen, P., Brambati, B., Carvalho, Dierikx, Elliston, S., Nunez, Osswald, W, Vicari, M. , Ethical guidance on human embryonic and fetal tissue
transplantation: A European overview, Medicine, Health Care and Philosophy 5, 79-90 (2002)
167
Ruitenberg, M.J., Plant, G.W., Christensen, C.L., Blits, B.,Niclou, S.P., Harvey, A.R., Boer, G.J., Verhaagen, J., Viral vector-mediated gene expression in olfactory ensheating glia implants in the lesioned rat spinal cord, Gene Therapy 9, 135-146 (2002)
166
Boer G.J., Widner H., Clinical neurotransplantation: core assessment protocol rather than sham surgery as control, Brain Research Bull. 58, 547-553 (2002)
165
Harvey R.R., Kamphuis, W., Eggers, R., Symons, N.A., Blits, B., Niclou, S., Boer, G.J., Verhaagen, J., Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors, Mol. Cell Neuroscience 21, 141-157 (2002)
164
Blits, B., Boer, G.J., Verhaagen, J., Pharmacological, cell and gene therapy strategies to promote spinal cord regeneration, Cell Transplantation 11, 593-613 (2002)
163
Ruitenberg, M.J., Eggers, R, Boer, G.J., Verhaagen, J., Adeno-associated viral vectors as agents for gene delivery application in disorders and trauma of the central nervous system, Methods 28,  182-194 (2002)

2001
162
Dekkers, W.J.M., Boer, G.J., Sham surgery in patients with Parkinson’s disease: is it morally acceptable? J. Medical Ethics 27, 151-156 (2001)
161
Boer, G.J., van Esseveldt, K.E., Dijkhuizen, P.A., Hermens, W.T.J.M.C., te Beek, E.T., van Heerikhuize, J.J., Poldervaart, H.A., Verhaagen, J, Adenoviral vector-mediated expression of neurtrophin-3 increases neuronal survival in suprachiasmatic nucleus grafts, Exp. Neurology 169,  364-375 (2001)

2000
160
Boer, G.J., The Network of European CNS Transplantation And Restoration (NECTAR) - an introduction on the occasion of its tenth meeting, Cell Tranplant. 9, 133-137 (2000)
159
Blits, B., Dijkhuizen, P.A., Hermens, T.J.M.C., Van Esseveldt, K.E., Boer, G.J., Verhaagen, J., The use of adenoviral vectors and ex vivo transduced neurotransplants: towards promotion of neuroregeneration, Cell Transplant. 9, 169-178 (2000)
158
Van Esseveldt, K.E., Lehman, M.N., Boer, G.J., The suprachiasmatic nucleus and the circadian time-keeping system revisited, Brain Res. Rev. 33, 34-77 (2000)
157
Blits, B., Dijkhuizen, P.A., Boer, G.J., Verhaagen, J., Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of ijured rat corticospinal tract fibers and improves hindlimb function, Exp. Neurol. 164, 25-37 (2000)

1999
156
Boer, G.J., Van Esseveldt, K.E., Van der Geest, B.A.M., Duindam, H., Rietveld, W.J., Vasopressin-deficient suprachiasmatic nucleus (SCN) grafts re-instate circadian rhythmcity in SCN-lesioned arhythmic rats, Neuroscience 89, 375-385 (1999)
155
Van Esseveldt, K.E., Van der Geest, B.A.M.,Duindam, H., Rietveld, W.P., Boer, G.J., Circadian rhythmicity of vasopressin levels in the cerebrospinal fluid of suprachiasmatic nucleus-lesioned and -grafted rats, J. Biol. Rhythms 14, 27-35 (1999)
154
Hassink, G.C., Van Esseveldt, K.E., Dijkhuizen, P.A., Verhaagen, J. and Boer, G.J., Ontogeny of neurotrophin receptor TrkC expression in the rat forebrain and anterior hypothalamus with special emphasis on the suprachiasmatic nucleus, Neuroscience 92, 705-712 (1999)
153
Boer, G.J., Ethical issues in neurografting of human embryonic cells, Theor. Medicine Bioethics 20, 461-475 (1999)
152
Blits, B., Dijkhuizen, P.A., Carlstedt, T.P., Poldervaart, H., Schiemanck, S, Boer, G.J., Verhaagen, J., Adenoviral vector-mediated expression of a foreign gene in peripheral nerve tissue bridges implanted in the injured perpiheral and central nervous system, Exp. Neurol. 160, 256-267 (1999)

1998
151
Van Esseveldt, K.E., Hermens, W.T.J.M.C., Verhaagen, J., Boer, G.J., Transplantation of fetal rat suprachiasmatic nucleus (SCN) genetically modified via adenovirus-mediated gene transfer. In Excerpta Medica Int. Congress Series 1152 ‘Biological Clocks. Mechanisms and Applications’, ed. Y. Touitou, Elsevier, Amsterdam (1998) 97-102
150
Van Esseveldt, K.E., Hermens, W.T.J.M.C., Verhaagen, J., Boer, G.J., Transgene expression in rat fetal brain grafts is maintained for 7 months after ex vivo adenoviral vector-mediated gene transfer, Neurosci. Lett. 240, 116-120 (1998)
149
Boer, G.J., Van Esseveldt, K.E., Rietveld, W.J., Cellular requirements of suprachiasmatic nucleus transplants for restoration of circadian rhythm, Chronobiol. Int. 15, 551-566 (1998)
148
Rijks, L.J., van den Bos, J.C., van Doremalen, P.A., Boer, G.J., de Bruin, K., Doornbos, T., Vekemans, J.A., Posthumus, M.A., Janssen, A.G., van Royen, E.A., Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E) 21 [123I]Iodo 11beta nitrato 19 norp regna 1,3,5 (10),20 tetraene 3,17 diol (E [123I]NIVE), Nucl. Med. Biol. 4, 411-421 (1998)
147
Rijks, L.J., van den Bos, J.C., van Doremalen, P.A., Boer, G.J., de Bruin, K., Janssen, A.G., van Royen, E.A., New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization, Nucl. Med. Biol. 8, 791-798 (1998)

1997
146
Boer, G.J., Van Esseveldt, K.E., Hermens, W.T.J.M.C., Liu, R., Verhaagen, J., Long-term transgene expression in fetal rat suprachiasmatic nucleus neurografts following ex vivo adenoviral vector-mediated gene transfer. Exp. Neurol. 145, 535-545 (1997)
145
Boer, G.J., Neurotransplantation of the biological clock in mammals, importance and perspectives, Biol. Rhythm Res. 28, 272-282 (1997)
144
Booij, J., Tissingh, G., Winogrodzka, A., Boer, G.J., Stoof, J.C., Wolters, E.Ch., Van Royen, E.A., Practical benefit of [123I]FP-CIT SPECT in the demonstration of the dopaminergic deficit in Parkinson’s disease, Eur. J. Nucl. Med. 24, 68-71 (1997)
143
Booij, J., Tissingh, G., Boer, G.J., Speelman, J.D., Stoof, J.C., Janssen, A.G.M., Wolters, E.Ch., Van Royen, E.A., [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry 62, 133-140 (1997)
142
Dubois, E.A., Somsen, G.A., Van den Bos, J.C., Janssen, A.G.M., Batink, H.D., Boer, G.J., Van Royen, E.A., Van Zwieten, P.A., Development of radioligands for the imaging of cardiac ß-adrenoceptors using SPECT. Part II: Pharmacological characterization in vitro and in vivo of new 123I-labelled ß-adrenoceptor antagonists, Nucl. Med. Biol. 24, 9-13 (1997)
141
Hoes, M.W.N., Duindam, H., Boer, G.J., Marani, E., Rietveld, W.J., Transplantation of fetal SCN in normal rhythmic rats induces changes in circadian rhythmicity of eating, Biol. Rhythm Res. 28,  283-298 (1997)
140
Rijks, L.J., Bakker, P.J., Van Tienhoven, G., Noorduyn, L.A., Boer, G.J., Rietbroek, R.C., Taat, C.W., Janssen, A.G., Veenhof, C.H., Van Royen, E.A., Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine 123 labeled Z MIVE. J. Clin. Oncol. 15, 2536-45 (1997)
139
Rijks, L.J.M., Boer, G.J., Endert, E., De Bruin, K., Janssen, A.G.M., Van Royen, E.A., The Z-isomer of 11ß-methoxy-17-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer. Eur. J. Nucl. Med. 24, 65-75 (1997)
138
Van den Bos, J.C., Van Doremalen, P.A.P.M., Dubois, E.A., Somsen, G.A., Vekemans, J.A.J.M., Janssen, A.G.M., Boer, G.J., Pfaffendorf, M., Van Royen, E.A., Van Zwieten, P.A., Development of radioligands for the imaging of cardiac ß-adrenoceptors using SPECT. Part I: Asymetric synthesis and structural characterisation of five new iodine-containing ß-adrenoceptor antagonist derivatives. Nucl. Med. Biol. 24, 1-7 (1997)
137
Van Esseveldt, K.E., Liu, R., Hermens, W.T.J.M.C., Verhaagen, J., Boer, G.J., Adenoviral vector-mediated gene transfer and neurotransplantation: possibilities and limitations in grafting of the fetal suprachiasmatic nucleus, J. Neurosc. Meth. 71, 113-123 (1997)
136
Booij, J., Andringa, G., Rijks, L.J.M., Vermeulen, J., De Bruin, K., Boer, G.J., Janssen, A.G.M., Van Royen, E.A., [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys, Synapse 27, 183-190 (1997)

1996
135
Boer, G.J., The self-restraining ethical guidelines of NECTAR for the clinical neurotransplantation investigations, Cognitio Humana - Dynamik des Wissens und der Werte (Eds. C. Hubig and H. Poser). Proceedings XVII. German Congress for Philosophy, Leipzig, pp.1420-1427 (1996)
134
Dubois, E.A., Somsen, G.A., Van den Bos, J.C., Janssen, A.G.M., Boer, G.J., Batink, H.J., Van Royen, E.A., Pfaffendorf, M., Van Zwieten, P.A., Pharmacological characterization in vitro and in vivo of 123I-labeled derivatives of the ß-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac ß-receptors, J. Nuclear Cardiology, 3, 242-252 (1996)
133
Dubois, E.A., Kam, K.L., Somsen, G.A., Boer, G.J., De Bruin, K., Batink, H.D., Pfaffendorf, M., Van Royen, E.A., Van Zwieten, P.A., Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension. Eur. J. Nucl. Med. 23, 901-908 (1996)
132
Dubois, E.A., Van den Bos, J.C., Doornbos, T., Van Dooremalen A.P.M., Somsen, G.A., Vekemans, J.J., Janssen, A.G.M., Batink, H.D., Boer, G.J., Pfaffendorf, M., Van Royen, E.A., Van Zwieten, P.A., Synthesis, in vitro and in vivo characteristics of an iodinated analogue of the ß-adrenoceptor antagonist carazolol. J. Med. Chem., 39, 3256-3262 (1996)
131
Korting, C, Van Zwieten, E.J., Boer, G.J., Ravid, R. and Swaab, D.F. Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease. Brain Res., 706, 151-154 (1996)
130
Rijks, L.J.M., Boer, G.J., Endert, E., De Bruin, K., Schoonen, W.G.E.J., Janssen, A.G.M., Van Royen, E.A., The stereoisomers of 17-[123I]iodovinylestradiol and its 11-methoxy derivative evaluated for their estrogen receptor binding in human MCF-7 cells and rat uterus, and distribution in immature rat, Eur. J. Nuclear Medicin, 23, 295-307 (1996)
129
Rijks, L.J.M., Booij, J., Doornbos T., Boer, G.J., Ronken, E., De Bruin, K., Vermeulen, R.J., Janssen, G.M., Van Royen, E.A., In vitro and in vivo characterization of newly developed ionidated 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}piperazine derivatives in rat; limited value as dopamine transporter SPECT ligands. Synapse, 23, 201-207 (1996)
128
Van Lookeren-Campagne, M., Verheul H.B., Vermeulen, J.P., Balazs, R., Boer, G.J., Nicolay, K. Developmental changes in NMDA-induced cell swelling and its transition to necrosis measured with 1H magnetic resonance imaging, impedence and histology. Dev. Brain Res., 93,109-119 (1996)

1995
127
Boer, G.J., Kelleman, A.A., Baker, R.E., Te Riele, P., Feenstra, M.G.P., Botterblom, M.H.A., Erdtsieck-Ernste, B.H.W., Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neonatal explants is seen only with the beta-1, not with the beta-2 subtype. Neurochem. Int., 20, 579-586 (1995)
126
Boer, G.J., The key issues of embryonic and fetal tissue transplantation. In: Ethical aspects of human reproduction (Eds. C. Sureau and F. Shenfield). John Libbey Eurotext, Paris (1995) pp. 164-168
125
Boer, G.J., Feenstra, M.G.P., Botterblom, M.J.A., Korse, V., Te Riele, P., Early postnatal appearance of enhanced noradrenaline content in the brain of vasopressin-deficient Brattleboro rat; normal adrenoceptor densities and influences of vasopressin treatment, Int. J. Develop. Neurosc., 13, 63-74 (1995)
124
Resink, A., Villa, M., Boer, G.J., Möhler, H., Balázs, R., Agonist-induced down-regulation of NMDA receptors in cerebellar granule cells in culture. Eur. J. Neurosc., 7, 1700-1706 (1995)
123
Van Lookeren-Campagne, M., Vermeulen, J.P., Boer, G.J., Balázs, R., Treatment with NMDA receptor antagonists does not affect developmental changes in NMDA receptor properties in vivo, Neurochem. Int., 27, 355-366 (1995)

1994
122
Boer, G.J., Quak, J., De Vries, M.C., Heinsbroek, R.P.W., Mild sustained effects of neonatal vasopressin and oxytocin treatment on brain growth and behavior of rat. Peptides, 15, 229-236 (1994)
121
Boer, G.J. (on behalf of the Network of European CNS Transplantation and Restoration (NECTAR), Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. J. Neurol., 242, 1-13 (1994)
120
Ramakers, G.J.A., Van Galen, H., Feenstra, M.G.P., Corner, M.A., Boer, G.J., Activity-dependent plasticity of inhibitory and excitatory amino acid transmitter systems in cultures rat cerebral cortex. Int. J. Developm. Neurosc., 12, 611-621 (1994)
119
Resink, A., Hack, N., Boer, G.J., Balázs, R., Growth conditions differentially modulate the vulnerability of developing cerebellar granule cells to excitatory amino acids. Brain Res. 655, 222-232 (1994)
118
Van Veldhuizen, M.J.A., Feenstra, M.G.P., Boer, G.J., Effects of neonatal exposure to clonidine on basal and activated central noradrenaline metabolism and in vivo overflow. Dev. Brain Res., 79, 275-282 (1994)
117
Van Veldhuizen, M.J.A., Feenstra, M.G.P., Botterblom, M.H.A., Boer, G.J., Increased 2-adrenoceptor mediated regulation of adult rat brain noradrenaline overflow after chronic neonatal exposure to propranolol; a microdialysis study. Brain Res. 646, 19-25 (1994)
116
Van Veldhuizen, M.J.A., Feenstra, M.G.P., Boer, G.J., Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain. Brain Res. 635, 238-248 (1994)

1993
115
Boer, G.J., Van der Hee, R., Feenstra, M.G.P., Alpha-2 adrenceptor assayed in rat brain by the new ligand [3H]RX821002. Biogenic Amines 9, 259-269 (1993)
114
Boer, G.J., Griffioen, H.A., Duindam, H., Van der Woude, T.P. and Rietveld, W.J., Light/dark effects of behavioral rhythms in suprachiasmatic nucleus implants, J. Interdisc. Cycle Res. 24, 118-136 (1993)
113
Boer, G.J., Snijdewint, F.G.M., Licht, R., te Riele, P., Increased loss of brain DNA in the neonatal vasopressin-deficient Brattleboro rat, but not in normal rat treated with vasopressin antagonist. Neurosci. Lett. 156, 17-20 (1993)
112
Boer, G.J. Vasopressin and oxytocin receptors in the developing brain. In: I.S. Zagon and P.J. McLaughlin (Eds.) Receptors in the Developing Nervous System, Chapman & Hall, London (1993) pp. 225-248.
111
Boer, G.J., Chronic oxytocin treatment during late gestation and lactation impairs development of rat offspring. Neurotoxicol. Teratol. 15, 383-389 (1993)
110
Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P., Boer, G.J., Perinatal in¬fluence of ß-adrenergic drugs on the noradrenergic system of the rat brain. Gen. Pharmac. 24, 1069-1078 (1993)
109
Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P., Botterblom, M., Boer, G.J., Developmental changes in rat brain monoamine metabolism and beta-adrenoceptor subtypes after chronic prenatal exposure to propranolol. Neurochem. Int. 22, 589-598 (1993)
108
Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P., Botterblom, M., Boer, G.J., Postnatal exposure to the beta-adrenoceptor agonist clenbuterol has regionally selective direct and long-term effects on rat brain beta-adrenoceptors and monoamine metabolism. Dev. Brain Res. 71, 27-35 (1993)
107
Griffioen, H.A., Duindam, H., Van der Woude, T.P., Rietveld, W.J., Boer, G.J., Functional development of fetal suprachiasmatic nucleus grafts in suprachiasmatic nucleus-lesioned rats. Brain Res. Bull. 31, 145-160 (1993)
106
Rietveld, W.J., Marani, E., Hoes, M.W.N., Boon, M.E., Griffioen, H.A., Boer, G.J., The use of neurobiological tools in the analysis of the central control of circadian rhythmicity. In New functional aspects of the supra¬chias-matic nucleus of the hypothalamus (Nakagawa, H., Oomura, Y., Nagai, K. eds.) John Libbey, pp. 193-197 (1993)
105
Van der Post, J.A.M., Konijnenberg, A., Boer, K., Schaap, M.C.L., Van Boxtel, C.E.A., Sturk, A., Boer, G.J., Swaab, D.F., Gestational hypertension is not associated with altered platelet vasopressin binding and cytosolic Ca2+ concentration. Am. J. Obstet. 169, 1169-1178 (1993)
104
Van Veldhuizen, M.J.A., Feenstra, M.G.P., Heinsbroek, R.P.W., Boer, G.J., In vivo microdialysis of cortical noradrenaline overflow: effects of several -adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Brit. J. Pharmacol. 109, 655-660 (1993)

1992
103
Baker, R.E., Vermeulen, J.P., Boer, G.J., NMDA receptor levels in chronically depolarized long-term neonatal rat neocortical explants. Int. J. Dev. Neuroscience 10, 413-419 (1992)
102
Boer, G.J., Griffioen, H.A., Saeed, P., Grafted fetal suprachiasmatic nucleus cells survive much better in tissue pieces than in suspension. Rest. Neurol. Neurosc. 4, 261-269 (1992)
101
Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P., Botterblom, M.H.A., De Barrios, J. and Boer, G.J., Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol. Br. J. Pharmacol. 105, 37-44 (1992)
100
Feenstra, M.G.P., Van Galen, H. and Boer, G.J., Early postnatal clonidine treatment results in altered regional catecholamine utilisation in adult rat brain. Psychopharmacology, 106, 19-25 (1992)
99
Gorter, J., Botterblom, M.H.A., Feenstra, M.G.P. and Boer, G.J., Chronic neonatal NMDA receptor blockade with MK-801 results in changes in mo¬no¬amine metabolism in the adult rat. Neurosc. Lett. 137, 97-100 (1992)
98
Griffioen, H.A., Van der Beek, E.M., Boer, G.J., Gelatin embedding to preserve lesion-damaged hypothalami and intracerebroventricular grafts for vibratome slicing and immunocytochemistry. J. Neurosci. Methods 43, 43-47 (1992)
97
Resink, A., Boer, G.J., Balázs, R., Treatment with excitatory amino acids or high K+ and NMDA receptors in cerebellar granule cells. NeuroReport 3, 757-760 (1992)
96
Verhoeff, N.P.L.G., Bobeldijk, M., Van Breukel, A.I.M., Van Vlies, B., Maas, M.A.W., Boer, G.J., Feenstra, M.G.P., Erdtsieck-Ernste, E., De Bruin, K., Olivier, G., Van Royen, E.A., In vitro and in vivo binding of muscarinic cholinergic receptors with 125I-iododexetimide in rat brain and heart. Nuclear Medicine 28 (suppl.) 212-215 (1992)

1991
95
Boer, G.J. and Fujii, T., Outline of functional neuroteratology. In: Fujii, T. and Boer, G.J. (Eds.) Functional Neuroteratology of Short-term Exposure to Drugs - Correlation between Structural or Biochemical Alterations and Functional Endpoints. Teikyo University Press (1991) pp. 1-4.
94
Boer, G.J., Neuropeptides: a new class of transmitters, a new class of functional teratogens. In: Fujii, T. and Boer, G.J. (Eds.) Functional Neuroteratology of Short-term Exposure to Drugs - Correlation between Structural or Biochemical Alterations and Functional Endpoints. Teikyo University Press (1991) pp. 73-85.
93
Erdtsieck-Ernste, B.H.W., Feenstra, M.G.P., Boer, G.J. and Van Galen, H., Chronic propranolol treatment in developing rats: acute and lasting effects on monoamines and beta-adrenergic receptors in the rat brain. Brain Res. Bull. 26, 731-737 (1991)
92
Erdtsieck-Ernste, B.H.W., Feenstra, M.G.P. and Boer, G.J., Pre- and post¬natal developmental changes of adrenoceptor subtypes in rat brain. J. Neurochem., 57, 897-903 (1991)
91
Nicholson, H.D., Guldenaar, S.E.F., Boer, G.J. and Pickering, B.T., Testi¬cular oxytocin: effects of intratesticular oxytocin in the rat. J. Endo¬crinology 130, 231-238 (1991)
90
Ramakers, G.J.A., De Graan, P.N.E., Oestreicher, A.B., Boer, G.J., Corner, M.A. and Gispen, W.H., Developmental changes in B50 (GAP43) in primary cultures of cerebral cortex: content and phosphorylation of B50. Int. J. Dev. Neurosci. 9, 231-241 (1991)
89
Ramakers, G.J.A. and Boer, G.J., Chronic suppression of bioelectric activity and cell survival in primary cultures of rat cerebral cortex: biochemical observations. Eur. J. Neurosc. 3, 154-161 (1991)
88
Verhoeff, N.P.L.G., Bobeldijk, M., Feenstra, M.G.P., Boer, G.J., Maas, M.A.W., Erdtsieck-Ernste, B.H.W., De Bruin, K. and Van Royen, E.A., In vitro and in vivo D2-dopamine receptor binding with 123I-S(-)iodobenzamide (123I-IBZM) in rat and human brain. Nucl. Med. Biol. 18, 837-846 (1991)

1990
87
Boer, G.J. and Griffioen, H.A., Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro rat and the arhythmic rat. Eur. J. Morphology 28, 330-345 (1990)
86
Boer, G.J., Feenstra, M.G.P., Erdtsieck-Ernste, E., Gorter, J.A. and Mirmiran, M.A., Lasting effects of early noradrenergic receptor occupation on brain noradrenaline turnover and on beta-receptors. Dev. Pharmacol. Ther. 15, 224-233 (1990)
85
Boer, G.J., Brain development and the influence of chemicals and environment. Syllabus on "Plasticity of the nervous system" Neuroscience Amsterdam (1990)
84
Feenstra, M.G.P., Snijdewint, F.G.M., Van Galen, H. and Boer, G.J., Widespread alterations in central noradrenaline, dopamine and serotonin systems in the Brattleboro rat not related to the local absence of vasopressin. Neurochem. Res. 15, 283-288 (1990)
83
Gonzalez, B.J., Leroux, P., Boer, G.J. and Vaudry, H., Expression of somatostatin receptors is impaired in the cerebellum of developing Brattleboro rats. Brain Res, 532, 115-119 (1990).
82
Heinsbroek, R.P.W., Van Haaren, F., Feenstra, M.G.P., Van Galen, H., Boer, G.J. and Van de Poll, N.E., Sex differences in the effects of inescapable footshock on central catecholaminergic and serotonergic activity. Pharmacol. Biochem. Behav. 37, 539-550 (1990)
81
Mullaart, E., Boerrigter, M.E.T.I., Boer, G.J. and Vijg, J., Spontaneous DNA breaks in the rat brain during development and aging. Mutation Research 237, 9-15 (1990)
80
Van Tol, H.H.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, P.H., Hypothalamic oxytocin mRNA during development of the Brattleboro rat. Neurosci. Res. Comm. 7, 25-33 (1990)
79
Van Veldhuizen, M.J.A., Feenstra, M.G.P., Boer, G.J. and Westerink, B.H.C., Microdialysis studies on cortical noradrenaline release: basic characteristics, significance of extracellular calcium and massive post-mortem increase. Neurosci. Lett. 119, 233-236 (1990)

1989
78
Herzberg, N.H., Goudsmit, E., Kruisbrink, J. and Boer, G.J., Testosterone treatment restores reduced vasopressin binding sites in the kidney of the aged rat. J. Endocrinol., 123, 59-63 (1989)
77
Shewey, L.M., Boer, G.J., Szot, P. and Dorsa, D.M., Regulation of vasopressin receptors and phosphoinositide hydrolysis in the septum of heterozygous and homozygous Brattleboro rats. Neuroendocrinology 50, 292-298 (1989)
76
Snijdewint, F.G.M., Van Leeuwen, F.W. and Boer, G.J., Ontogeny of vasopressin and oxytocin binding sites in the brain of Wistar and Brattleboro rats as demonstrated by lightmicroscopical autoradiography. J. Chem. Neuroanatomy 2, 3-17 (1989)

1988
75
Boer, G.J., Snijdewint, F.G.M. and Swaab, D.F., Neuropeptides and functional neuroteratology. Progr. Brain Res. 73, 245-264 (1988)
74
Boer, G.J., Van Heerikhuize, J.J. and Van der Woude, T.P., Elevated serum oxytocin of the vasopressin deficient Brattleboro rat is present throughout life and is not sensitive to treatment with vasopressin. Acta Endocrinol. 117, 442-450 (1988)
73
Kruisbrink, J., Mirmiran, M. and Boer, G.J., Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist and vasoactive intestinal polypeptide on circadian rhythm and sleep wake patterns in rat, In: Sleep '86, eds. W.P. Koella, F. Obál, H. Schulz, P. Visser, Gustav Fischer Verlag, Stuttgart (1988) 332-334
72
Kruisbrink J., Van Heerikhuize, J.J. and Boer, G.J., Osmoregulation with long term enhanced cerebrospinal fluid levels of vasopressin or vasoactive intestinal polypeptide. J. Endocrinol. 117, 207-214 (1988)
71
Mirmiran, M., Kruisbrink, J., Bos, N.P.A., Van der Werf D. and Boer, G.J., Decrease of rapid eye movement sleep in the light by intraventricular application of a VIP antagonist in the rat. Brain Res. 458, 192-194 (1988)
70
Snijdewint, F.G.M., Boer, G.J. and Swaab, D.F., Prenatal development of the Brattleboro rat is influenced by genotype and lysine vasopressin treatment of the mother. Biol. Neonate 53, 295-304 (1988)
69
Snijdewint, F.G.M. and Boer, G.J., Neonatal treatment with vasopressin antagonist dP[Tyr(Me)2]AVP, but not with vasopressin antagonist d(CH2)5[Tyr(Me)2]AVP, inhibits body and brain development and induces polyuria in the rat. Neurotoxicol. Teratol. 10, 321-325 (1988)
68
Swaab, D.F., Boer, G.J. and Feenstra, M.G.P., Concept of functional neuroteratology and the importance of neurochemistry. Progr. Brain Res. 73, 245-264 (1988)

1987
67
Boer, G.J., Development of vasopressin systems and their functions. In: 'Vasopressin; principles and properties', D.M. Gash and G.J. Boer (Eds.), Plenum Press, N.Y. (1987) 117-174 
66
Boer, G.J. and Kruisbrink, J., A polymeric controlled drug delivery device for peptides based on a surface desorption/diffusion mechanism. Biomaterials 8, 265-274 (1987)
65
Kruisbrink, J., Mirmiran, M., V.d. Woude, T.P. and Boer G.J., Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep wake rhythm in the rat. Brain Res. 419, 76-86 (1987)
64
Ravid, R. and Boer, G.J., Ligand anti ligand immuno cytochemistry for revealing neuropeptide binding sites in kidney and rat brain. ETP/ENA/IBRO practical course `Molecular Neuroanatomy' (Eds. F.W. Van Leeuwen, R.M. Buijs and C.W. Pool), Neth. Inst. for Brain Res., Amsterdam, pp. 279-287 (1987)

1986
63
Edwards, P.M., Kuiters, R.R.F., Boer, G.J. and Gispen, W.H., Recovery from peripheral nerve transection is accelerated by local application of alpha MSH by means of microporous Accurel(R) polypropylene tubes. J. Neurol. Sci. 74, 171-176 (1986)
62
Kruisbrink, J., Van der Woude, T.P., Boer, G.J. and Mirmiran, M., Manipulation of vasopressin level in the cerebrospinal fluid of the rat by means of an easily interchangeable controlled delivery Accurel mini device. J. Neurosci. Meth. 17, 103-108 (1986)
61
Kruisbrink, J. and Boer, G.J., The use of [3H]vasopressin for in vivo studies of controlled drug delivery from an Accurel/collodion device in the Brattleboro rat. J. Pharm. Pharmacol. 38, 893-897 (1986)
60
Ravid, R., Swaab, D.F., Van der Woude, T.P. and Boer, G.J., Immunocytochemically stained binding sites for oxytocin and alpha melanocyte stimulating hormone in rat brain following ventricular administration. Brain Res. 379, 404-408 (1986)
59
Ravid, R., Swaab, D.F. and Van der Woude, Tj.P. and Boer, G.J., Immunocytochemicallystained vasopressin binding sites in rat brain Ventricular application of vasopressin/Accurel in the Brattleboro rat. J. Neurol. Sci. 76, 317-333 (1986)
58
Snijdewint, F.G.M. and Boer, G.J., Vasopressin and vasopressin antagonists applied to neonatal Wistar rat: effects on body and brain development and water metabolism. Neurobehav. Toxicol. Teratol. 8, 213-217 (1986)
57
Södersten, P., Boer, G.J., De Vries, G.J., Buijs, R.M. and Melin, P., Effects of vasopressin on female sexual behavior in male rats. Neurosci. Lett. 69, 188-191 (1986)
56
Van der Sluis, P.J. and Boer, G.J., The relevance of various tests to study specificity in immunocytochemical staining. Cell Biochem. Function 4, 1-17 (1986)
55
Van der Sluis, P.J., Boer, G.J. and Swaab, D.F., Vasopressin and oxytocin in the developing rat brain as shown by isoelectric focusing of radioimmunoassayable peptides. Developm. Brain Res. 26, 85-90 (1986)
54
Van Tol, H.H.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, J.P.H., Postnatal development of vasopressin mRNA content in supraoptic and paraventricular nucleus of the Wistar rat. Neurosci. Lett. 65, 1-6 (1986)
53
Van Tol, H.H.M., Voorhuis, T.A.M., Snijdewint, F.G.M., Boer, G.J. and Burbach, J.P.H., Vasopressin gene expression is alternated in the fetal Brattleboro rat. FEBS letters 204, 101-105 (1986)

1985
52
Boer, G.J., Vasopressin and brain development; studies using the Brattleboro rat. Peptides 6, Suppl. 1, 49-62 (1985)
51
Boer, G.J. and Swaab, D.F., Neuropeptide effects on brain development to be expected from behavioral teratology. Peptides 6, Suppl. 2, 21-28 (1985)
50
Boer, G.J., Hall, K. and Sara, V.R., Transient enhancement of serum somatostatin levels prior to weaning of growth impaired vasopressin deficient Brattleboro rats. J. Developm. Physiol. 7, 321-327 (1985)
49
Boer, G.J., Gash, D.M., Dick, L. and Schluter, N., Vasopressin neuron survival in neonatal Brattleboro rats; critical factors in graft development and innervation of the host brain. Neuroscience 15, 1087-1109 (1985)
48
Oosterbaan, H.P., Swaab, D.F. and Boer, G.J., Oxytocin and vasopressin in the rat do not readily pass from the mother to the amniotic fluid in late pregnancy. J. Develop. Phys. 7, 55-62 (1985)
47
Oosterbaan, H.P., Swaab, D.F., and Boer, G.J., The origin of amniotic oxytocin and vasopressin and their relationship to intra uterine growth retardation. Proceedings of Int. Symposium `Physiological Development of Fetus and Newborn', C.J. Jones and P.W. Nathanielz (Eds.), Academic Press, London (1985) 89-92 
46
Oosterbaan, H.P., Swaab, D.F. and Boer, G.J., Increased amniotic vasopressin levels in experimentally growth retarded rat foetuses. J. Devel. Physiol. 7, 89-97 (1985)
45
Snijdewint, F.G.M., Boer, G.J. and Swaab, D.F., Body and brain growth following continuous perinatal administration of arginine and lysine vasopressin to the homozygous Brattleboro rat. Developm. Brain Res. 22, 269-277 (1985)

1984
44
Boer, G.J. and Kruisbrink, J., Effects of continuousadministration of oxytocin by an Accurel device on parturition in the rat and on development and diuresis in the offspring. J. Endocr. 101, 121-129 (1984)
43
Boer, G.J., Dozy, H.M. and Uylings, H.B.M., Cerebellar DNA and tissue water changes in the brain of diabetes insipidus Brattleboro rats are already present at birth. Int. J. Devel. Neurosci. 2, 301-304 (1984)
42
Boer, G.J., Schluter, N. and Gash, D.H., A procedure for small volume brain grafting; vasopressin cells in neonatal and adult Brattleboro rats. J. Neurosci. Meth. 11, 39-45 (1984).
41
Boer, G.J., Kragten, J. and Swaab, D.F., Vasopressin fails to restore postnatally the stunted brain development in the Brattleboro rat, but affects water metabolism permanently. Neurobehav. Toxicol. & Teratol. 6, 103-109 (1984)
40
Boer, G.J., Van der Woude, T.P., Kruisbrink, J. and Van Heerikhuize, J., Succesful ventricular application of the miniaturized controlled delivery Accurel technique for sustained enhancement of cerebrospinal fluid peptide levels in the rat. J. Neurosci. Meth. 11, 281-289 (1984)
39
Kruisbrink, J. and Boer, G.J., Controlled long term release of small peptide hormones using the new microporous polypropylene polymer. Its application for vasopressin in the Brattleboro rat and its potential perinatal use. J. Pharm. Sci. 73, 1713-1718 (1984)

1983
38
Boer, G.J. and Swaab, D.F., Long term effects on brain and behaviour of early treatments with neuropeptides. In: Application of Behavioral Pharmacology in Toxicology, G. Zbinden, V. Cuomo, G. Racagni and B. Weiss (eds.), Raven Press, New York (1983) 251-263
37
Boer, G.J., Kruisbrink, J. and Van Pelt Heerschap, H., Long term and constant release of vasopressin from Accurel tubing; implantation in the Brattleboro rat. J. Endocrinol. 98, 147-152 (1983)
36
Boer, G.J. and Patel, A.J., Disorders of cell acquisition in the brain of Brattleboro rats deficient for vasopression. Neurochem. Internat. 5, 463-469 (1983)
35
Boer, G.J. and Rieutort, M., Serum levels of growth hormone during the stunted postnatal development of th evasopressin deficient Brattleboro rat. J. Endocrinol. 98, 351-356 (1983)
34
Gash, D.M., Boer, G.J., Notter, M.F.D. and Sladek Jr., J.R., Transplanted vasopressin neurons and central nervous system effects of vasopressin. In: The Neurohypophysis, B.A. Cross and G. Leng (eds.), Progress in Brain Research, Vol. 60, Elsevier Biomedical Press, Amsterdam (1983) 189-195
33
Gash, D.M., Boer, G.J., Notter, M.F.D. and Sladek Jr., J.R., Development and function of transplanted vasopressin neurons. Psychopharm. Bull. 19, 308-310 (1983)
32
Heinsbroek, R.P.W., Van Oyen, H.G., Van de Poll, N.E. and Boer, G.J., Failure of dexamethasone to influence sex differences in acquisition of discriminated leverpress avoidance. Pharmacol. Biochem. Behav. 19, 599-604 (1983)
31
Kok, T., Van der Sluis, P.J. and Boer, G.J., Chemical identification of vasopressin immunoreactive material present in the rat suprachiasmatic nucleus. Neuropeptides 3, 255-262 (1983)
30
Mirmiran, M., Scholtens, J., Van der Poll, N.E., Uylings, H.B.M., Van der Gugten, J. and Boer, G.J., Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behaviour in the rat. Devel. Brain Res. 7, 277-286 (1983)
29
Pool, Chr.W., Buijs, R.M., Swaab, D.F., Boer, G.J. and Van Leeuwen, F.W., On the way to a specific immunocytochemical localization. In: Immunohistochemistry (A.C. Cuello, ed.). IBRO Handbook Series "Methods in Neurosciences", John Wiley & Sons Ltd., New York/London (1983) 1-45
28
Swaab, D.F. and Boer, G.J., Neuropeptides and brain development. Current perils and future potentialities. J. Dev. Physiol. 5, 67-75 (1983)
27
Van der Sluis, P.J., Boer, G.J. and Pool, Chr.W., Fixation and immunoperoxidase staining of oligopeptides after isoelectric focussing in thin polyacrylamide slag gels. Anal. Biochem. 133, 226-232 (1983)

1982
26
Boer, G.J., Van Rheenen Verberg, C.M.F. and Uylings, H.B.M., Impaired brain development of the diabetes insipidus Brattleboro rat. Dev. Brain Res. 3, 557-575 (1982)
25
Boer, G.J., Boer, K. and Swaab, D.F., On the reproductive and developmental differences within the Brattleboro strain. Ann. N.Y. Acad. Sci. 394, 37-47 (1982)
24
Boer, G.J., Uylings, H.B.M., Patel, A.J., Boer, K. and Kragten, R., The regional impairment of brain development in the Brattleboro diabetes insipidus rat; some vasopressin supplementation studies. Ann. N.Y. Acad. Sci. 394, 703-719 (1982)
23
Grimmelikhuijzen, C.J.K., Dierickx, K. and Boer, G.J., An ancestral oxytocin/vasopressin like peptide is present in the nervous system of hydra. Neuroscience 7, 3191-3199 (1982)
22
Pool, C.W., Buijs, R.M. Swaab, D.F., Boer, G.J. and Van Leeuwen, F.W., Specificity in immunocytochemnistry. In: Course Manual 2nd EMBO practical course "Immunocytochemistry and it applications in brain research", F.W. Van Leeuwen, D.F. Swaab and R.M. Buijs (eds.),  Netherlands Institute for Brain Research, Amsterdam (1982) 93-128
21
Swaab, D.F., Boer, G.J., Boer, K., Oosterbaan, H.P. and Oosting, P.R., Neurohypophysial and intermediate lobe peptides in intrauterine growth and labour. In: Neuroendocrinology of Vasopressin, Corticoliberin and opiomelanocortins, A.J. Baertschi and J.J. Dreifuss (eds.), Academic Press, London (1982) 343-352

1981
20
Boer, K., Boer, G.J. and Swaab, D.F., Reproduction in Brattleboro rats with diabetes insipidus. J. Reprod. Fertil. 61, 273-280 (1981)
19
Swaab, D.F., Achterberg, P.W., Boer, G.J., Dogterom, J. and Van Leeuwen, F.W., The distribution of MSH and ACTH in the rat and human brain and its relation to the pituitary stores. In: Endogenous Peptides and Learning and Memory Processes, J.L. Martinez, R.A. Jensen, R.B. Messing, H. Rigter and J.L. McGaugh (eds.), Academic Press, New York (1981) 7-36

1980
18
Boer, G.J., Swaab, D.F., Uylings, H.B.M., Boer, K., Buijs, R.M. and Velis, D.N., Neuropeptides in rat brain development. In: Adaptive Capabilities of the Nervous System, P.S. McConnell, G.J. Boer, H.J. Romijn, N.E. Van de Poll and M.A. Corner (eds.), Progress in Brain Research, Vol. 53, Elsevier, Amsterdam (1980) 207-227
17
Boer, G.J., Pool, C.W., Van der Sluis, P.J. and Madlener, S., Identification of tissue antigens as part of a serum specificity test for immunocytochemistry. In: Course Manual of EMBO practical course "Immunocytochemistry and its application in brain research", G.J. Boer and D.F. Swaab (eds.), Netherlands Institute for Brain Research, Amsterdam (1980) 55-65
16
Boer, G.J., Buijs, R.M., Swaab, D.F. and De Vries, G.J., Vasopressin and the developing rat brain. Peptides 1 (Suppl. 1), 203-209 (1980)
15
Corner, M.A., Mirmiran, M., Bour, H.L.M.G., Boer, G.J., Van de Poll, N.E., Van Oyen, H.G. and Uylings, H.B.M., Does rapid eye movement sleep play a role in brain development? In: Adaptive Capabilities of the Nervous System, P.S. McConnell et al. (eds.), Progress in Brain Research, Vol. 53, Elsevier, Amsterdam (1980) 347-356
14
Mirmiran, M., Van de Poll, N. Van Oyen, H., Boer, G. and Corner, M., Lasting sequence of chronic treatment with chlorimipramine during early postnatal development in the rat. IRCS J. Med. Sci. 8, 200-202 (1980)
13
Pool, C.W., Swaab, D.F. and Boer, G.J., An approach to specificity in immunocytochemistry. In: Course Manual EMBO practical course "Immunocytochemistry and its application in brain research", G.J. Boer and D.F. Swaab (eds.), Netherlands Institute for Brain Research, Amsterdam (1980) 39-53

1978
12
Boer, G.J., Uylings, H.B.M., Van Rheenen Verberg, C.M.F. and Fisser, B, Postnatal brain development in rats with hereditary diabetes insipidus (Brattleboro strain). In: Hormones and Brain Development, G. Dörner and M. Kawasaki (eds.), Elsevier/North Holland Biomedical Press, Amsterdam (1978) 253-258
11
Swaab, D.F., Boer, G.J., Boer, K., Dogterom, J., Van Leeuwen, F.W. and Visser, M., Fetal neuroendocrine mechanisms in development and parturition. In: Maturation of the Nervous System, M.A. Corner, R.E. Baker, N.E. Van de Poll, D.F. Swaab and H.B.M. Uylings (eds.), Progress in Brain Research, Vol. 48, Elsevier, Amsterdam (1978) 277-289
10
Swaab, D.F., Boer, G.J. and Visser, M., The fetal brain and intrauterine growth. Postgrad. Med. J. 54 (Suppl. 1), 63-69 (1978)

1976
9
Boer, G.J., The role of pituicytes in the rat neurohypophysis; an explanatory investigation using histo and microchemistry. Thesis, University of Amsterdam, February 12 (1976)
8
Boer, G.J., Van Leeuwen, F.W., Swaab, D.F. and Nolten, J.W.L., Acid phosphatase activity in the rat neurohypophysis during increased levels of gonadotrophic hormones, in diabetes insipidus (Brattleboro strain) and after water loading. Acta Endocrinol. 81, 697-706 (1976)
7
Boer, G.J., Nolten, J.W.L., Koenders, Y. and Van Rheenen-Verberg, C.M.F., Enzymic preparation of neurosecretosome and pituicyte enriched fractions from the rat neurohypophysis. Brain Res. 114, 257-277 (1976)
6
Boer, G.J. and Van Rheenen-Verberg, C.M.F., Acid phosphatase in rat neurohypophyseal dispersions and its fractions enriched for neurosecretosomes and pituicytes after water deprivation and lactation. Brain Res. 114, 279-292 (1976)

1975
5
Boer, G.J., A microassay for arylamidase activity. Anal. Biochem. 59, 410-415 (1974)
4
Boer, G.J., A simplified microassay of DNA and RNA using ethidium bromide. Anal. Biochem. 65, 225 231 (1975)

1974
3
Boer, G.J. and Jongkind, J.F., Quantitative enzyme activity changes in the neural lobe of the rat following water deprivation and lactation. J. Neurochem. 22, 965-970 (1974)
2
Boer, K., Boer, G.J. and Swaab, D.F., Does the hypothalamoneurohypophyseal system play a role in gestation length or the course of parturition? In: Integrative Hypothalamic Activity, D.F. Swaab and J.P. Schadé (eds.), Progress in Brain Research, Vol. 41, Elsevier, Amsterdam (1974)  307-319

1972
1
Boer, G.J., Carbonic anhydrase activity in rat neurohyphysis following osmotic stress. J. Histochem. Cytochem. 20, 621-626 (1972)